Urinary BTA: Indicator of bladder cancer or of hematuria

Makito Miyake, Steve Goodison, Wasia Rizwani, Shanti Ross, H. Bart Grossman, Charles J. Rosser

Research output: Contribution to journalArticle

34 Scopus citations

Abstract

Background: In this study, we investigated the influence of hematuria on the performance of the bladder tumor antigen (BTA) tests in a clinical cohort and in an experimental model. Materials and methods: Urine samples from a cohort of 126 subjects (64 with BCa and 62 controls) were analyzed by ELISA for hemoglobin and BTA. The experimental model involved the spiking of urine with blood from the same subject, and hemoglobin, red blood cell count, and BTA levels (BTA stat

Original languageEnglish (US)
Pages (from-to)869-873
Number of pages5
JournalWorld Journal of Urology
Volume30
Issue number6
DOIs
StatePublished - Dec 2012

Keywords

  • BTA
  • Bladder cancer
  • Complement factor H
  • Diagnosis
  • Hematuria

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Urinary BTA: Indicator of bladder cancer or of hematuria'. Together they form a unique fingerprint.

  • Cite this

    Miyake, M., Goodison, S., Rizwani, W., Ross, S., Bart Grossman, H., & Rosser, C. J. (2012). Urinary BTA: Indicator of bladder cancer or of hematuria. World Journal of Urology, 30(6), 869-873. https://doi.org/10.1007/s00345-012-0935-9